Literature DB >> 32048078

Understanding PrEP Persistence: Provider and Patient Perspectives.

Nicole D Laborde1, Patrick M Kinley2, Matthew Spinelli3, Eric Vittinghoff4, Ryan Whitacre5, Hyman M Scott3,6, Susan P Buchbinder4,6,7.   

Abstract

PrEP persistence, or PrEP use over time, has been shown to be short, with most PrEP users stopping within 6-12 months. Furthermore, those most vulnerable to HIV often use PrEP for shorter periods. This qualitative study explores patient, provider, and contextual factors that influence PrEP persistence. In interviews with 25 PrEP users and 18 PrEP providers in San Francisco's safety net clinics, we analyze the perceived benefits and difficulties of taking PrEP, including structural barriers. We identify different steps in receipt of PrEP care (clinic visits and lab tests, pharmacy interactions, and medication adherence), and describe barriers and facilitators for providers and patients at each step. Our findings suggest that drop-in visits, streamlined testing, standing orders for labs, and 90-day PrEP prescriptions are highly desirable for many PrEP users. Also important are the proactive provision of adherence support and counseling, and referrals for housing, substance use, and mental health services.

Entities:  

Keywords:  HIV Prevention; Persistence; PrEP

Mesh:

Substances:

Year:  2020        PMID: 32048078      PMCID: PMC8054778          DOI: 10.1007/s10461-020-02807-3

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  35 in total

Review 1.  How Stigma Surrounding the Use of HIV Preexposure Prophylaxis Undermines Prevention and Pleasure: A Call to Destigmatize "Truvada Whores".

Authors:  Sarah K Calabrese; Kristen Underhill
Journal:  Am J Public Health       Date:  2015-08-13       Impact factor: 9.308

2.  Pre-exposure prophylaxis prescribing and retention in care among heterosexual women at a community-based comprehensive sexual health clinic.

Authors:  Oni J Blackstock; Viraj V Patel; Uriel Felsen; Connie Park; Sachin Jain
Journal:  AIDS Care       Date:  2017-02-01

3.  Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.

Authors:  Robert M Grant; Peter L Anderson; Vanessa McMahan; Albert Liu; K Rivet Amico; Megha Mehrotra; Sybil Hosek; Carlos Mosquera; Martin Casapia; Orlando Montoya; Susan Buchbinder; Valdilea G Veloso; Kenneth Mayer; Suwat Chariyalertsak; Linda-Gail Bekker; Esper G Kallas; Mauro Schechter; Juan Guanira; Lane Bushman; David N Burns; James F Rooney; David V Glidden
Journal:  Lancet Infect Dis       Date:  2014-07-22       Impact factor: 25.071

4.  Integrating HIV Preexposure Prophylaxis (PrEP) Into Routine Preventive Health Care to Avoid Exacerbating Disparities.

Authors:  Sarah K Calabrese; Douglas S Krakower; Kenneth H Mayer
Journal:  Am J Public Health       Date:  2017-10-19       Impact factor: 9.308

5.  HIV Pre-exposure Prophylaxis Prescribing Through Telehealth.

Authors:  Joanne D Stekler; Vanessa McMahan; Lark Ballinger; Luis Viquez; Fred Swanson; Jon Stockton; Beth Crutsinger-Perry; David Kern; John D Scott
Journal:  J Acquir Immune Defic Syndr       Date:  2018-04-15       Impact factor: 3.731

Review 6.  HIV among Black men who have sex with men (MSM) in the United States: a review of the literature.

Authors:  Cathy Maulsby; Greg Millett; Kali Lindsey; Robin Kelley; Kim Johnson; Daniel Montoya; David Holtgrave
Journal:  AIDS Behav       Date:  2014-01

7.  Preexposure prophylaxis guidelines have low sensitivity for identifying seroconverters in a sample of young Black MSM in Chicago.

Authors:  Nicola Lancki; Ellen Almirol; Leigh Alon; Moira McNulty; John A Schneider
Journal:  AIDS       Date:  2018-01-28       Impact factor: 4.177

8.  Examining levels of risk behaviors among black men who have sex with Men (MSM) and the association with HIV acquisition.

Authors:  Risha Irvin; Snigdha Vallabhaneni; Hyman Scott; John K Williams; Leo Wilton; Xin Li; Susan Buchbinder
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

9.  Missed Visits Associated With Future Preexposure Prophylaxis (PrEP) Discontinuation Among PrEP Users in a Municipal Primary Care Health Network.

Authors:  Matthew A Spinelli; Hyman M Scott; Eric Vittinghoff; Albert Y Liu; Rafael Gonzalez; Alicia Morehead-Gee; Monica Gandhi; Susan P Buchbinder
Journal:  Open Forum Infect Dis       Date:  2019-02-26       Impact factor: 3.835

10.  Patterns and clinical consequences of discontinuing HIV preexposure prophylaxis during primary care.

Authors:  Douglas Krakower; Kevin M Maloney; Victoria E Powell; Ken Levine; Chris Grasso; Kathy Melbourne; Julia L Marcus; Kenneth H Mayer
Journal:  J Int AIDS Soc       Date:  2019-02       Impact factor: 5.396

View more
  19 in total

1.  Sleep Disturbance is Associated with Missing PrEP Doses Among Young Black Sexual Minority Men in The N2 study.

Authors:  Jade Pagkas-Bather; Dustin T Duncan; Yen-Tyng Chen; John Cursio; Natascha Del Vecchio; Kenneth H Mayer; Justin Knox; Hillary Hanson; Rebecca Eavou; John A Schneider
Journal:  AIDS Behav       Date:  2022-06-04

2.  The effect of an HIV preexposure prophylaxis panel management strategy to increase preexposure prophylaxis prescriptions.

Authors:  Parya Saberi; Marie C D Stoner; Kristin Ming; Nadra E Lisha; J Carlo Hojilla; Hyman M Scott; Albert Y Liu; Wayne T Steward; Mallory O Johnson; Torsten B Neilands
Journal:  AIDS       Date:  2022-06-22       Impact factor: 4.632

Review 3.  Promises and challenges: cabotegravir for preexposure prophylaxis.

Authors:  Matthew A Spinelli; Beatriz Grinsztejn; Raphael J Landovitz
Journal:  Curr Opin HIV AIDS       Date:  2022-03-04       Impact factor: 4.061

4.  Substance Use and Healthcare Utilization Across the Pre-Exposure Prophylaxis (PrEP) Care Cascade among Black and Latino Men Who Have Sex with Men.

Authors:  Ryan J Watson; Ethan Morgan; Charlene Collibee; Jolaade Kalinowski; Casey Cunningham; E Jennifer Edelman; Philip Chan; Lisa A Eaton
Journal:  Subst Use Misuse       Date:  2022-08-08       Impact factor: 2.362

5.  Provider Perspectives on Factors Affecting the PrEP Care Continuum Among Black Cisgender Women in the Midwest United States: Applying the Consolidated Framework for Implementation Research.

Authors:  Amy K Johnson; Maria Pyra; Samantha Devlin; A Ziggy Uvin; Shemeka Irby; Cori Blum; Eric Stewart; Lisa Masinter; Sadia Haider; Lisa R Hirschhorn; Jessica P Ridgway
Journal:  J Acquir Immune Defic Syndr       Date:  2022-07-01       Impact factor: 3.771

6.  Determinants of Willingness to Use PrEP Among Gay and Bisexual Men in China Before Implementation: A Structural Equation Modeling Assessment.

Authors:  Tracy Shicun Cui; Benjamin Lane; Yumeng Wu; Jing Ma; Rong Fu; Jianhua Hou; Siyan Meng; Lu Xie; Yuzhou Gu; Xiaojie Huang; Huang Zheng; Yanling Ma; Na He; Kathrine Meyers
Journal:  AIDS Behav       Date:  2022-08-31

7.  Lessons Learned from an HIV Pre-Exposure Prophylaxis Coordination Program in San Francisco Primary Care Clinics.

Authors:  Isha Shrestha; Kristin Ming; Veronica Jimenez; James Wendelborn; Alexander Vazquez; Wayne Steward; Hyman Scott; Parya Saberi
Journal:  AIDS Res Hum Retroviruses       Date:  2022-06-16       Impact factor: 1.723

8.  Recognizing and disrupting stigma in implementation of HIV prevention and care: a call to research and action.

Authors:  Sarit A Golub; Rachel A Fikslin
Journal:  J Int AIDS Soc       Date:  2022-07       Impact factor: 6.707

9.  Examining the Potential of Pre-exposure Prophylaxis (PrEP) for HIV Prevention in a Community Sample of Persons Who Use Stimulants Living in the Southern United States.

Authors:  Sheri L Towe; Catherine A Sullivan; Mehri S McKellar; Christina S Meade
Journal:  AIDS Behav       Date:  2021-05

10.  Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya.

Authors:  Patrick Owuor Mbullo; Lisa Ruth Hirschhorn; Maya Jackson-Gibson; Ashley Uzoamaka Ezema; Wicklife Orero; Irene Were; Ramael Osasogie Ohiomoba
Journal:  BMC Public Health       Date:  2021-07-01       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.